STERIS Plc engages in the provision of healthcare and life science products and service solutions. Its segments include Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. Its Healthcare segment provides a comprehensive offering for healthcare providers worldwide, focused on sterile processing departments and procedural centers, such as operating rooms and endoscopy suites. AST segment supports medical device and pharmaceutical manufacturers through a global network of contract sterilization and laboratory testing facilities, and integrated sterilization equipment and control systems. Its Life Sciences segment provides a comprehensive offering of products and services designed to support biopharmaceutical and medical device research and manufacturing facilities, in particular those focused on aseptic manufacturing. Its portfolio includes a full suite of consumable products, equipment maintenance, specialty services, and capital equipment.
The most recent EPS for STERIS plc is $2.52, not beating expectations of $2.55.
How did STERIS plc STE's revenue perform in the last quarter?
STERIS plc revenue for the last quarter is $2.52
What is the revenue estimate for STERIS plc?
According to 8 of Wall street analyst, the revenue estimate of STERIS plc range from $1.68B to $1.54B
What's the earning quality score for STERIS plc?
STERIS plc has a earning quality score of B+/49.053852. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does STERIS plc report earnings?
STERIS plc next earnings report is expected in 2026-05-05
What are STERIS plc's expected earnings?
STERIS plc expected earnings is $1.49B, according to wall-street analysts.
Did STERIS plc beat earnings expectations?
STERIS plc recent earnings of $1.49B beat expectations.